Table 4.
Citation | Camille et al22 | Adigun and Adniran27 | Mzezewa et al24 | |||
---|---|---|---|---|---|---|
1. Were the 2 groups similar and recruited from the same population? | U | U | U | |||
2. Were the exposures measured similarly to assign people to both exposed and unexposed groups? | U | U | U | |||
3. Was the exposure measured in a valid and reliable way? | U | U | U | |||
4. Were confounding factors identified? | U | U | U | |||
5. Were strategies to deal with confounding factors stated? | N | U | U | |||
6. Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)? | N | U | U | |||
7. Were the outcomes measured in a valid and reliable way? | U | U | U | |||
8. Was the follow-up time reported and sufficient to be long enough for outcomes to occur? | U | N | U | |||
9. Was follow-up complete, and if not, were the reasons to loss to follow up described and explored? | N | N | N | |||
10. Were strategies to address incomplete follow-up utilized? | N | N | N | |||
11. Was appropriate statistical analysis used? | N | N | N | |||
Quality assessment using JBI checklist.
N, no; U, unclear.